These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 36918752

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characteristics associated with response to subcutaneously administered anti-CGRP monoclonal antibody medications in a real-world community cohort of persons living with migraine: A retrospective clinical and genetic study.
    Chase BA, Semenov I, Rubin S, Meyers S, Mark A, Makhlouf T, Chirayil TT, Maraganore D, Wei J, Zheng SL, Xu J, Epshteyn A, Pham A, Frigerio R, Markopoulou K.
    Headache; 2024 Jan; 64(1):68-92. PubMed ID: 38071464
    [Abstract] [Full Text] [Related]

  • 23. Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.
    Vernieri F, Brunelli N, Messina R, Costa CM, Colombo B, Torelli P, Quintana S, Cevoli S, Favoni V, d'Onofrio F, Egeo G, Rao R, Filippi M, Barbanti P, Altamura C.
    J Headache Pain; 2021 Dec 18; 22(1):154. PubMed ID: 34922444
    [Abstract] [Full Text] [Related]

  • 24. Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study.
    Barbanti P, Aurilia C, Egeo G, Proietti S, Torelli P, d'Onofrio F, Carnevale A, Tavani S, Orlando B, Fiorentini G, Colombo B, Filippi M, Bonassi S, Cevoli S, Italian Migraine Registry (I-GRAINE) study group.
    J Neurol; 2024 May 18; 271(5):2605-2614. PubMed ID: 38342785
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.
    Muñoz-Vendrell A, Campoy S, Caronna E, Alpuente A, Torres-Ferrus M, Nieves Castellanos C, Olivier M, Campdelacreu J, Prat J, Camiña Muñiz J, Molina Martínez FJ, Mínguez-Olaondo A, Ruibal Salgado M, Santos Lasaosa S, Navarro Pérez MP, Morollón N, López Bravo A, Cano Sánchez LM, García-Sánchez SM, García-Ull J, Rubio-Flores L, Gonzalez-Martinez A, Quintas S, Echavarría Íñiguez A, Gil Luque S, Castro-Sánchez MV, Adell Ortega V, García Alhama J, Berrocal-Izquierdo N, Belvís R, Díaz-Insa S, Pozo-Rosich P, Huerta-Villanueva M.
    J Headache Pain; 2023 Jun 02; 24(1):63. PubMed ID: 37268904
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies - insights from the German NeuroTransData registry.
    Hong JB, Israel-Willner H, Peikert A, Schanbacher P, Tozzi V, Köchling M, Reuter U, Raffaelli B, NTD Study Group.
    J Headache Pain; 2024 Jun 03; 25(1):90. PubMed ID: 38825722
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of anti-CGRP-targeted therapy on migraine aura: Results of an observational case series study.
    Cresta E, Bellotti A, Rinaldi G, Corbelli I, Sarchielli P.
    CNS Neurosci Ther; 2024 Feb 03; 30(2):e14595. PubMed ID: 38332541
    [Abstract] [Full Text] [Related]

  • 29. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ.
    Headache; 2018 Nov 03; 58 Suppl 3():238-275. PubMed ID: 30242830
    [Abstract] [Full Text] [Related]

  • 30. Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
    Torres-Ferrús M, Gallardo VJ, Alpuente A, Caronna E, Giné-Ciprés E, Pozo-Rosich P.
    Cephalalgia; 2024 Feb 03; 44(2):3331024231222923. PubMed ID: 38307497
    [Abstract] [Full Text] [Related]

  • 31. Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study.
    Iannone LF, Romozzi M, Russo A, Saporito G, De Santis F, Ornello R, Sances G, Vaghi G, Tassorelli C, Albanese M, Guerzoni S, Casalena A, Vollono C, Calabresi P, Prudenzano MP, Mampreso E, Volta GD, Valente MR, Avino G, Chiarugi A, Sacco S, Pistoia F, Italian Headache Registry (RICe) study group.
    Eur J Neurol; 2024 Dec 03; 31(12):e16450. PubMed ID: 39285638
    [Abstract] [Full Text] [Related]

  • 32. Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
    Raffaelli B, Terhart M, Overeem LH, Mecklenburg J, Neeb L, Steinicke M, Reuter U.
    Cephalalgia; 2022 Apr 03; 42(4-5):326-334. PubMed ID: 34579559
    [Abstract] [Full Text] [Related]

  • 33. Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
    Russo CV, Saccà F, Braca S, Sansone M, Miele A, Stornaiuolo A, De Simone R.
    Cephalalgia; 2023 Apr 03; 43(4):3331024231161809. PubMed ID: 36946234
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies.
    Ferreira VL, Mainka FF, Wiens A, Pontarolo R.
    Clin Drug Investig; 2023 Sep 03; 43(9):669-680. PubMed ID: 37665501
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months.
    Caronna E, Gallardo VJ, Alpuente A, Torres-Ferrus M, Pozo-Rosich P.
    J Headache Pain; 2021 Oct 07; 22(1):120. PubMed ID: 34620085
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series.
    Kaltseis K, Filippi V, Frank F, Eckhardt C, Schiefecker A, Broessner G.
    BMC Neurol; 2023 Apr 28; 23(1):174. PubMed ID: 37118682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.